Low Bone Mineral Density and Calcium Levels as Risks for Mortality in Patients with Self-Discontinuation of Anti-Osteoporosis Medication
Chun-Sheng Hsu,
Shin-Tsu Chang,
Yuan-Yang Cheng,
Hsu-Tung Lee,
Chih-Hui Chen,
Ya-Lian Deng,
Chiann-Yi Hsu and
Yi-Ming Chen
Additional contact information
Chun-Sheng Hsu: Department of Physical Medicine and Rehabilitation, Taichung Veterans General Hospital, Taichung 40705, Taiwan
Shin-Tsu Chang: Department of Physical Medicine and Rehabilitation, Taichung Veterans General Hospital, Taichung 40705, Taiwan
Yuan-Yang Cheng: Department of Physical Medicine and Rehabilitation, Taichung Veterans General Hospital, Taichung 40705, Taiwan
Hsu-Tung Lee: College of Medicine, National Chung Hsing University, Taichung 402202, Taiwan
Chih-Hui Chen: School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan
Ya-Lian Deng: Department of Nursing, Taichung Veterans General Hospital, Taichung 40705, Taiwan
Chiann-Yi Hsu: Department of Medical Research, Taichung Veterans General Hospital, Taichung 40705, Taiwan
Yi-Ming Chen: College of Medicine, National Chung Hsing University, Taichung 402202, Taiwan
IJERPH, 2021, vol. 19, issue 1, 1-11
Abstract:
Bone mass density (BMD) has been used universally in osteoporosis diagnosis and management. Adherence to anti-osteoporosis medication is related to mortality risk. This study aimed to investigate the relationship between mortality and low BMD of the femoral neck and vertebra among patients self-discontinuing anti-osteoporosis medication. Between June 2016 and June 2018, this single-center retrospective study recruited 596 participants who self-discontinued anti-osteoporosis medication. Patients were categorized into four groups by BMD of the right femoral neck and lumbar spine. Occurrence and causes of mortality were obtained from medical records. Independent risk factors and the five-year survival of various levels of BMD were analyzed by Cox regression and the Kaplan–Meier survival analysis. BMD value and serum calcium level were significantly lower in the mortality group ( p < 0.001). Compared to the reference, the adjusted hazard ratio (HR) for all-cause mortality in patients with lower BMD of both the lumbar spine and femoral neck was 3.03. The five-year cumulative survival rate was also significantly lower (25.2%, p < 0.001). A low calcium level was also associated with mortality (HR: 0.87, 95% CI: 0.76–0.99, p = 0.033). In conclusion, lower BMD and calcium levels were associated with higher mortality risk in patients with poor adherence. Hence, patients self-discontinuing anti-osteoporosis medication should be managed accordingly.
Keywords: osteoporosis; bone mineral density; mortality; serum calcium; adherence (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2021
References: View complete reference list from CitEc
Citations:
Downloads: (external link)
https://www.mdpi.com/1660-4601/19/1/197/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/1/197/ (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2021:i:1:p:197-:d:710894
Access Statistics for this article
IJERPH is currently edited by Ms. Jenna Liu
More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().